Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
Double-blind, placebo-controlled, single ascending and multiple dose study. Approximately 32 healthy adult male and female subjects will be given a single capsule of MYMD1 to determine its safety, tolerability, and pharmacokinetic properties. The study data will guide the establishment of an optimum therapeutic dose.
Epistemonikos ID: 6c3591423255957e3e3f75b625af51a3fd9d5e3e
First added on: Oct 02, 2023